Anzeige
Meldung des Tages: USA erklären Kupfer zur Chefsache – dieser Nevada-Explorer bohrt bereits

Illumina News

Aktie
WKN:  927079 ISIN:  US4523271090 US-Symbol:  ILMN Land:  USA
107,36 €
-3,22 €
-2,91%
22:44:27 Uhr
Depot/Watchlist
Marktkapitalisierung *
18,15 Mrd. €
Streubesitz
-
KGV
28,17
Nachhaltigkeits-Score
50 %
Index-Zuordnung
Nasdaq Composite Index
Weiter abwärts? Short handeln - Jetzt mit Hebel 5,50: VJ38F5
Werbung

Illumina News

08.01.26 - PR Newswire
Illumina Appoints Dr. Eric Green as Chief Medical Officer
Illumina Appoints Dr. Eric Green as Chief Medical Officer PR Newswire
06.01.26 - PR Newswire
Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis
Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis PR Newswire
16.12.25 - PR Newswire
Illumina To Webcast Upcoming Investor Conference
Illumina To Webcast Upcoming Investor Conference PR Newswire
11.12.25 - PR Newswire
/C O R R E C T I O N -- MyOme, Inc/
/C O R R E C T I O N -- MyOme, Inc/ PR Newswire
24.11.25 - wallstreetONLINE Redaktion
Biotech rein, Chips raus: Cathie Wood: Die größte Portfolio-Umschichtung des Jahres – was ist da los?
Cathie Wood setzt auf eine neue Marktphase: ARK Invest kauft massiv Biotech und KI-​Infrastruktur und trennt sich von bekannten Tech- und Diagnostikwerten. Was steckt ...
12.11.25 - PR Newswire
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study
Illumina whole-​genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study PR Newswire
11.11.25 - PR Newswire
Illumina To Webcast Upcoming Investor Conference
Illumina To Webcast Upcoming Investor Conference PR Newswire
10.11.25 - PR Newswire
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks PR Newswire
05.11.25 - PR Newswire
Illumina Responds to Positive Updates from Chinese Ministry of Commerce
Illumina Responds to Positive Updates from Chinese Ministry of Commerce PR Newswire
30.10.25 - PR Newswire
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025 PR Newswire
15.10.25 - PR Newswire
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights PR Newswire
15.10.25 - PR Newswire
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
Illumina constellation mapped read technology uncovers hard-​to-see genomic insights in GeneDx pilot PR Newswire
14.10.25 - PR Newswire
Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025
Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025 PR Newswire
01.10.25 - PR Newswire
Illumina launches new business to accelerate technology and data-driven discovery
Illumina launches new business to accelerate technology and data-​driven discovery PR Newswire
23.09.25 - PR Newswire
Illumina advances personalized cancer care with new pharma development partnerships
Illumina advances personalized cancer care with new pharma development partnerships PR Newswire
18.09.25 - PR Newswire
Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine
Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine PR Newswire
15.09.25 - LYNX Analysen
Illumina: Endlich wieder auf Erfolgskurs?
Illumina hat eine turbulente Geschichte hinter sich. Die jüngsten Quartals­zahlen deuten jedoch auf eine Rückkehr zu alter Stärke hin. Jetzt vollständige Analyse lesen
07.09.25 - PR Newswire
Illumina® Protein Prep bringt neue Erkenntnisse aus der Proteomik für eine verbesserte Arzneimittelforschung und -entwicklung
Illumina® Protein Prep bringt neue Erkenntnisse aus der Proteomik für eine verbesserte Arzneimittelforschung und -entwicklung PR Newswire
03.09.25 - PR Newswire
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development PR Newswire
03.09.25 - PR Newswire
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development PR Newswire

Newssuche

Videos

newspaper
04.03.26 +13,80%
ROHÖL mit Ziel MINUS 40$?!?
Fundierte Strategien für den Handel der wichtigen News in einem Seminarpaket, plus transparenter ... Mehr »